Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines
- 1 February 2020
- journal article
- review article
- Published by Elsevier BV in Kidney International
- Vol. 97 (2), 266-278
- https://doi.org/10.1016/j.kint.2019.09.024
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation
- Irish Nephrology Society
- Wellcome Trust
- Wolfson Foundation
This publication has 119 references indexed in Scilit:
- Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysisThe Lancet, 2012
- The contribution of chronic kidney disease to the global burden of major noncommunicable diseasesKidney International, 2011
- Long Interdialytic Interval and Mortality among Patients Receiving HemodialysisThe New England Journal of Medicine, 2011
- The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trialThe Lancet, 2011
- Low glomerular filtration rate and risk of stroke: meta-analysisBMJ, 2010
- Intensive Blood-Pressure Control in Hypertensive Chronic Kidney DiseaseThe New England Journal of Medicine, 2010
- Rosuvastatin and Cardiovascular Events in Patients Undergoing HemodialysisThe New England Journal of Medicine, 2009
- Effect of Frequent Nocturnal Hemodialysis vs Conventional Hemodialysis on Left Ventricular Mass and Quality of LifeJAMA, 2007
- Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: The ARIC StudyKidney International, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002